February 24, 2015
Tuesday’s RegMed rhythms: waiting for just about anything
February 24, 2015
Flat open expected; RegMed selling pressures set-in
February 23, 2015
RegMed investing – foresight needs more than a dash of hindsight
February 20, 2015
RegMed, another option expiration date
February 20, 2015
Friday’s RegMed rhythms: the chill lessens
February 18, 2015
Wednesday’s RegMed rhythms: eking out pricing as momentum clouds speculation
February 17, 2015
RegMed sector rises but trading ranges are slipping indiscernibly
February 17, 2015
Tuesday’s RegMed rhythms: the paradox of a good day, it will soon end
February 17, 2015
Histogenics (HSGX) reports Q4/14 and FY14 Results on Thursday, 2/26/15 at 8 a.m. ET
February 11, 2015
RegMed’s watching the traders buy and say goodbye as investors become the fall guy
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.